title: Expectations in the treatment of retinal diseases: neuroprotection.
authors.affiliation: Nuffield Laboratory of Ophthalmology, University of Oxford, Oxford, UK. neville.osborne@eye.ox.ac.uk
authors.forename: N N
authors.initials: NN
authors.lastname: Osborne
authors.forename: G
authors.initials: G
authors.lastname: Chidlow
authors.forename: J P
authors.initials: JP
authors.lastname: Wood
authors.forename: K G
authors.initials: KG
authors.lastname: Schmidt
authors.forename: R
authors.initials: R
authors.lastname: Casson
authors.forename: J
authors.initials: J
authors.lastname: Melena
mesh_terms: D000818:Animals; D002470:Cell Survival / Q000187:drug effects; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D020419:Photoreceptor Cells, Vertebrate / Q000187:drug effects; D012164:Retinal Diseases / Q000188:drug therapy*; D012165:Retinal Ganglion Cells / Q000187:drug effects
chemical_list: D018696:Neuroprotective Agents